Healthcare Professionals

Nuwiq^® (Antihemophilic Factor, Recombinant, B-Domain deleted, simoctocog alfa)

Nuwiq^® is indicated for the treatment and prophylaxis of bleeding in patients of all ages suffering with hemophilia A (congenital factor VIII deficiency).Nuwiq^® is also indicated for the peri-operative treatment of hemophilia A patients.

Patient Resources

Nuwiq® patient brochure, ProCare home care infusion program, reconstitution guide, storage information and cooler bag.

Safety Information

Important safety information, warnings, precautions and how to report suspected adverse events.

[Twitter Widget Error] You need to authenticate your Twitter App first. Go to Highend Options > Social Links. Read the documentation to find out more.

Product Information

Reconstitution Instructions

Clinical Studies

Nuwiq^® (Antihemophilic Factor, Recombinant, B-Domain deleted, simoctocog alfa)

Nuwiq^® is indicated for the treatment and prophylaxis of bleeding in patients of all ages suffering with hemophilia A (congenital factor VIII deficiency).Nuwiq^® is also indicated for the peri-operative treatment of hemophilia A patients.

Patient Resources

Safety Information

Most Commented Posts

Recent Comments

Responsive Ads

Most Liked Posts

Find us on

Product Information

Reconstitution Instructions

Clinical Studies

Nuwiq® (Antihemophilic Factor, Recombinant, B-Domain deleted, simoctocog alfa)

Nuwiq® is indicated for the treatment and prophylaxis of bleeding in patients of all ages suffering with hemophilia A (congenital factor VIII deficiency).Nuwiq® is also indicated for the peri-operative treatment of hemophilia A patients.

Patient Resources

Safety Information

Most Commented Posts

Recent Comments

Responsive Ads

Most Liked Posts

Find us on

Nuwiq^® (Antihemophilic Factor, Recombinant, B-Domain deleted, simoctocog alfa)

Nuwiq^® is indicated for the treatment and prophylaxis of bleeding in patients of all ages suffering with hemophilia A (congenital factor VIII deficiency).Nuwiq^® is also indicated for the peri-operative treatment of hemophilia A patients.